BioCanRx – Canada’s Immunotherapy Network

The BioCanRx network is accelerating to the clinic Canada’s most promising and innovative cancer biotherapeutics designed to save lives and enable a better quality of life. BioCanRx invests in innovations and the best the field has to offer, always looking for a clear path to the clinic for the benefit of patients. BioCanRx works in partnership with industry, charities and other agencies to translate immune-based technologies from the lab into early phase clinical trials, and addresses socio-economic considerations necessary for their adoption by health-care systems. Through an innovative, collaborative funding process, BioCanRx is becoming a world-leader in the translation, manufacture and adoption of innovative cancer immunotherapies for the benefit of all patients. The network is developing and attracting the talent needed for a thriving health biotechnology sector in Canada. BioCanRx receives funding from the federal government's Networks of Centres of Excellence, and support from industry, the provinces and many national charities.